Loading…

Construction of autologous human heart valves based on an acellular allograft matrix

Tissue engineered heart valves based on polymeric or xenogeneic matrices have several disadvantages, such as instability of biodegradable polymeric scaffolds, unknown transfer of animal related infectious diseases, and xenogeneic rejection patterns. To overcome these limitations we developed tissue...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2002-09, Vol.106 (12 Suppl 1), p.I63-I68
Main Authors: Cebotari, Serghei, Mertsching, Heike, Kallenbach, Klaus, Kostin, Sawa, Repin, Oleg, Batrinac, Aurel, Kleczka, Carmen, Ciubotaru, Anatol, Haverich, Axel
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c511t-9b175f59ab684093b66666175b4b40959515057011b2312cb2b00352db1d463c3
cites cdi_FETCH-LOGICAL-c511t-9b175f59ab684093b66666175b4b40959515057011b2312cb2b00352db1d463c3
container_end_page I68
container_issue 12 Suppl 1
container_start_page I63
container_title Circulation (New York, N.Y.)
container_volume 106
creator Cebotari, Serghei
Mertsching, Heike
Kallenbach, Klaus
Kostin, Sawa
Repin, Oleg
Batrinac, Aurel
Kleczka, Carmen
Ciubotaru, Anatol
Haverich, Axel
description Tissue engineered heart valves based on polymeric or xenogeneic matrices have several disadvantages, such as instability of biodegradable polymeric scaffolds, unknown transfer of animal related infectious diseases, and xenogeneic rejection patterns. To overcome these limitations we developed tissue engineered heart valves based on human matrices reseeded with autologous cells. Aortic (n=5) and pulmonary (n=6) human allografts were harvested from cadavers (6.2+/-3.1 hours after death) under sterile conditions. Homografts stored in Earle's Medium 199 enriched with 100 IU/mL Penicillin-Streptomycin for 2 to 28 days (mean 7.3+/-10.2 days) showed partially preserved cellular viability (MTT assay) and morphological integrity of the extracellular matrix (H-E staining). For decellularization, valves were treated with Trypsin/EDTA resulting in cell-free scaffolds (DNA-assay) with preserved extracellular matrix (confocal microscopy). Primary human venous endothelial cells (HEC) were cultivated and labeled with carboxy-fluorescein diacetate-succinimidyl ester in vitro. After recellularization under fluid conditions, EC were detected on the luminal surfaces of the matrix. They appeared as a monolayer of positively labeled cells for PECAM-1, VE-cadherin and Flk-1. Reseeded EC on the acellular allograft scaffold exhibited high metabolic activity (MTT assay). Earle's Medium 199 enriched with low concentration of antibiotics represents an excellent medium for long time preservation of extracellular matrix. After complete acellularization with Trypsin/EDTA, recellularization under shear stress conditions of the allogeneic scaffold results in the formation of a viable confluent HEC monolayer. These results represent a promising step toward the construction of autologous heart valves based on acellular human allograft matrix.
doi_str_mv 10.1161/01.cir.0000032900.55215.85
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72135328</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>208135471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-9b175f59ab684093b66666175b4b40959515057011b2312cb2b00352db1d463c3</originalsourceid><addsrcrecordid>eNpdkE1PwzAMhiMEYmPwF1C0A7eWOKnblRua-JImcRnnKGlT1qltRtJO8O9J2aRJ-GLZft7EfgmZA4sBUrhnEBe1i9kYgueMxYgcMF7gGZkC8iRKUOTnZBrmeZQJzifkyvttKFOR4SWZABeYZABTsl7azvduKPradtRWVA29beynHTzdDK3q6MYo19O9avbGU628KWkgw0AVpmmGRjmqmqBwquppq3pXf1-Ti0o13twc84x8PD-tl6_R6v3lbfm4igoE6KNcQ4YV5kqni4TlQqdjhJ5OdKgxR0CGGQPQXAAvNNfhYOSlhjJJRSFm5O7w7s7Zr8H4Xra1H7dSnQkHyIyDQMEXAZz_A7d2cF3YTXLgaZbmGQvQwwEqnPXemUruXN0q9yOBydF4yUAG4-XJePlnvFxgEN8efxh0a8qT9Oi0-AXJc33n</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212676970</pqid></control><display><type>article</type><title>Construction of autologous human heart valves based on an acellular allograft matrix</title><source>EZB Electronic Journals Library</source><creator>Cebotari, Serghei ; Mertsching, Heike ; Kallenbach, Klaus ; Kostin, Sawa ; Repin, Oleg ; Batrinac, Aurel ; Kleczka, Carmen ; Ciubotaru, Anatol ; Haverich, Axel</creator><creatorcontrib>Cebotari, Serghei ; Mertsching, Heike ; Kallenbach, Klaus ; Kostin, Sawa ; Repin, Oleg ; Batrinac, Aurel ; Kleczka, Carmen ; Ciubotaru, Anatol ; Haverich, Axel</creatorcontrib><description>Tissue engineered heart valves based on polymeric or xenogeneic matrices have several disadvantages, such as instability of biodegradable polymeric scaffolds, unknown transfer of animal related infectious diseases, and xenogeneic rejection patterns. To overcome these limitations we developed tissue engineered heart valves based on human matrices reseeded with autologous cells. Aortic (n=5) and pulmonary (n=6) human allografts were harvested from cadavers (6.2+/-3.1 hours after death) under sterile conditions. Homografts stored in Earle's Medium 199 enriched with 100 IU/mL Penicillin-Streptomycin for 2 to 28 days (mean 7.3+/-10.2 days) showed partially preserved cellular viability (MTT assay) and morphological integrity of the extracellular matrix (H-E staining). For decellularization, valves were treated with Trypsin/EDTA resulting in cell-free scaffolds (DNA-assay) with preserved extracellular matrix (confocal microscopy). Primary human venous endothelial cells (HEC) were cultivated and labeled with carboxy-fluorescein diacetate-succinimidyl ester in vitro. After recellularization under fluid conditions, EC were detected on the luminal surfaces of the matrix. They appeared as a monolayer of positively labeled cells for PECAM-1, VE-cadherin and Flk-1. Reseeded EC on the acellular allograft scaffold exhibited high metabolic activity (MTT assay). Earle's Medium 199 enriched with low concentration of antibiotics represents an excellent medium for long time preservation of extracellular matrix. After complete acellularization with Trypsin/EDTA, recellularization under shear stress conditions of the allogeneic scaffold results in the formation of a viable confluent HEC monolayer. These results represent a promising step toward the construction of autologous heart valves based on acellular human allograft matrix.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.cir.0000032900.55215.85</identifier><identifier>PMID: 12354711</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Aortic Valve - anatomy &amp; histology ; Aortic Valve - chemistry ; Aortic Valve - metabolism ; Bioprosthesis ; Cells, Cultured ; Collagen Type I - analysis ; Endothelium, Vascular - chemistry ; Extracellular Matrix - chemistry ; Heart Valve Prosthesis ; Humans ; Microscopy, Fluorescence ; Pulmonary Valve - anatomy &amp; histology ; Pulmonary Valve - chemistry ; Pulmonary Valve - metabolism ; Tissue Engineering - methods ; Transplantation, Homologous</subject><ispartof>Circulation (New York, N.Y.), 2002-09, Vol.106 (12 Suppl 1), p.I63-I68</ispartof><rights>Copyright American Heart Association, Inc. Sep 24, 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-9b175f59ab684093b66666175b4b40959515057011b2312cb2b00352db1d463c3</citedby><cites>FETCH-LOGICAL-c511t-9b175f59ab684093b66666175b4b40959515057011b2312cb2b00352db1d463c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12354711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cebotari, Serghei</creatorcontrib><creatorcontrib>Mertsching, Heike</creatorcontrib><creatorcontrib>Kallenbach, Klaus</creatorcontrib><creatorcontrib>Kostin, Sawa</creatorcontrib><creatorcontrib>Repin, Oleg</creatorcontrib><creatorcontrib>Batrinac, Aurel</creatorcontrib><creatorcontrib>Kleczka, Carmen</creatorcontrib><creatorcontrib>Ciubotaru, Anatol</creatorcontrib><creatorcontrib>Haverich, Axel</creatorcontrib><title>Construction of autologous human heart valves based on an acellular allograft matrix</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Tissue engineered heart valves based on polymeric or xenogeneic matrices have several disadvantages, such as instability of biodegradable polymeric scaffolds, unknown transfer of animal related infectious diseases, and xenogeneic rejection patterns. To overcome these limitations we developed tissue engineered heart valves based on human matrices reseeded with autologous cells. Aortic (n=5) and pulmonary (n=6) human allografts were harvested from cadavers (6.2+/-3.1 hours after death) under sterile conditions. Homografts stored in Earle's Medium 199 enriched with 100 IU/mL Penicillin-Streptomycin for 2 to 28 days (mean 7.3+/-10.2 days) showed partially preserved cellular viability (MTT assay) and morphological integrity of the extracellular matrix (H-E staining). For decellularization, valves were treated with Trypsin/EDTA resulting in cell-free scaffolds (DNA-assay) with preserved extracellular matrix (confocal microscopy). Primary human venous endothelial cells (HEC) were cultivated and labeled with carboxy-fluorescein diacetate-succinimidyl ester in vitro. After recellularization under fluid conditions, EC were detected on the luminal surfaces of the matrix. They appeared as a monolayer of positively labeled cells for PECAM-1, VE-cadherin and Flk-1. Reseeded EC on the acellular allograft scaffold exhibited high metabolic activity (MTT assay). Earle's Medium 199 enriched with low concentration of antibiotics represents an excellent medium for long time preservation of extracellular matrix. After complete acellularization with Trypsin/EDTA, recellularization under shear stress conditions of the allogeneic scaffold results in the formation of a viable confluent HEC monolayer. These results represent a promising step toward the construction of autologous heart valves based on acellular human allograft matrix.</description><subject>Aortic Valve - anatomy &amp; histology</subject><subject>Aortic Valve - chemistry</subject><subject>Aortic Valve - metabolism</subject><subject>Bioprosthesis</subject><subject>Cells, Cultured</subject><subject>Collagen Type I - analysis</subject><subject>Endothelium, Vascular - chemistry</subject><subject>Extracellular Matrix - chemistry</subject><subject>Heart Valve Prosthesis</subject><subject>Humans</subject><subject>Microscopy, Fluorescence</subject><subject>Pulmonary Valve - anatomy &amp; histology</subject><subject>Pulmonary Valve - chemistry</subject><subject>Pulmonary Valve - metabolism</subject><subject>Tissue Engineering - methods</subject><subject>Transplantation, Homologous</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpdkE1PwzAMhiMEYmPwF1C0A7eWOKnblRua-JImcRnnKGlT1qltRtJO8O9J2aRJ-GLZft7EfgmZA4sBUrhnEBe1i9kYgueMxYgcMF7gGZkC8iRKUOTnZBrmeZQJzifkyvttKFOR4SWZABeYZABTsl7azvduKPradtRWVA29beynHTzdDK3q6MYo19O9avbGU628KWkgw0AVpmmGRjmqmqBwquppq3pXf1-Ti0o13twc84x8PD-tl6_R6v3lbfm4igoE6KNcQ4YV5kqni4TlQqdjhJ5OdKgxR0CGGQPQXAAvNNfhYOSlhjJJRSFm5O7w7s7Zr8H4Xra1H7dSnQkHyIyDQMEXAZz_A7d2cF3YTXLgaZbmGQvQwwEqnPXemUruXN0q9yOBydF4yUAG4-XJePlnvFxgEN8efxh0a8qT9Oi0-AXJc33n</recordid><startdate>20020924</startdate><enddate>20020924</enddate><creator>Cebotari, Serghei</creator><creator>Mertsching, Heike</creator><creator>Kallenbach, Klaus</creator><creator>Kostin, Sawa</creator><creator>Repin, Oleg</creator><creator>Batrinac, Aurel</creator><creator>Kleczka, Carmen</creator><creator>Ciubotaru, Anatol</creator><creator>Haverich, Axel</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>20020924</creationdate><title>Construction of autologous human heart valves based on an acellular allograft matrix</title><author>Cebotari, Serghei ; Mertsching, Heike ; Kallenbach, Klaus ; Kostin, Sawa ; Repin, Oleg ; Batrinac, Aurel ; Kleczka, Carmen ; Ciubotaru, Anatol ; Haverich, Axel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-9b175f59ab684093b66666175b4b40959515057011b2312cb2b00352db1d463c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Aortic Valve - anatomy &amp; histology</topic><topic>Aortic Valve - chemistry</topic><topic>Aortic Valve - metabolism</topic><topic>Bioprosthesis</topic><topic>Cells, Cultured</topic><topic>Collagen Type I - analysis</topic><topic>Endothelium, Vascular - chemistry</topic><topic>Extracellular Matrix - chemistry</topic><topic>Heart Valve Prosthesis</topic><topic>Humans</topic><topic>Microscopy, Fluorescence</topic><topic>Pulmonary Valve - anatomy &amp; histology</topic><topic>Pulmonary Valve - chemistry</topic><topic>Pulmonary Valve - metabolism</topic><topic>Tissue Engineering - methods</topic><topic>Transplantation, Homologous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cebotari, Serghei</creatorcontrib><creatorcontrib>Mertsching, Heike</creatorcontrib><creatorcontrib>Kallenbach, Klaus</creatorcontrib><creatorcontrib>Kostin, Sawa</creatorcontrib><creatorcontrib>Repin, Oleg</creatorcontrib><creatorcontrib>Batrinac, Aurel</creatorcontrib><creatorcontrib>Kleczka, Carmen</creatorcontrib><creatorcontrib>Ciubotaru, Anatol</creatorcontrib><creatorcontrib>Haverich, Axel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cebotari, Serghei</au><au>Mertsching, Heike</au><au>Kallenbach, Klaus</au><au>Kostin, Sawa</au><au>Repin, Oleg</au><au>Batrinac, Aurel</au><au>Kleczka, Carmen</au><au>Ciubotaru, Anatol</au><au>Haverich, Axel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Construction of autologous human heart valves based on an acellular allograft matrix</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2002-09-24</date><risdate>2002</risdate><volume>106</volume><issue>12 Suppl 1</issue><spage>I63</spage><epage>I68</epage><pages>I63-I68</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>Tissue engineered heart valves based on polymeric or xenogeneic matrices have several disadvantages, such as instability of biodegradable polymeric scaffolds, unknown transfer of animal related infectious diseases, and xenogeneic rejection patterns. To overcome these limitations we developed tissue engineered heart valves based on human matrices reseeded with autologous cells. Aortic (n=5) and pulmonary (n=6) human allografts were harvested from cadavers (6.2+/-3.1 hours after death) under sterile conditions. Homografts stored in Earle's Medium 199 enriched with 100 IU/mL Penicillin-Streptomycin for 2 to 28 days (mean 7.3+/-10.2 days) showed partially preserved cellular viability (MTT assay) and morphological integrity of the extracellular matrix (H-E staining). For decellularization, valves were treated with Trypsin/EDTA resulting in cell-free scaffolds (DNA-assay) with preserved extracellular matrix (confocal microscopy). Primary human venous endothelial cells (HEC) were cultivated and labeled with carboxy-fluorescein diacetate-succinimidyl ester in vitro. After recellularization under fluid conditions, EC were detected on the luminal surfaces of the matrix. They appeared as a monolayer of positively labeled cells for PECAM-1, VE-cadherin and Flk-1. Reseeded EC on the acellular allograft scaffold exhibited high metabolic activity (MTT assay). Earle's Medium 199 enriched with low concentration of antibiotics represents an excellent medium for long time preservation of extracellular matrix. After complete acellularization with Trypsin/EDTA, recellularization under shear stress conditions of the allogeneic scaffold results in the formation of a viable confluent HEC monolayer. These results represent a promising step toward the construction of autologous heart valves based on acellular human allograft matrix.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>12354711</pmid><doi>10.1161/01.cir.0000032900.55215.85</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 2002-09, Vol.106 (12 Suppl 1), p.I63-I68
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_72135328
source EZB Electronic Journals Library
subjects Aortic Valve - anatomy & histology
Aortic Valve - chemistry
Aortic Valve - metabolism
Bioprosthesis
Cells, Cultured
Collagen Type I - analysis
Endothelium, Vascular - chemistry
Extracellular Matrix - chemistry
Heart Valve Prosthesis
Humans
Microscopy, Fluorescence
Pulmonary Valve - anatomy & histology
Pulmonary Valve - chemistry
Pulmonary Valve - metabolism
Tissue Engineering - methods
Transplantation, Homologous
title Construction of autologous human heart valves based on an acellular allograft matrix
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A45%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Construction%20of%20autologous%20human%20heart%20valves%20based%20on%20an%20acellular%20allograft%20matrix&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Cebotari,%20Serghei&rft.date=2002-09-24&rft.volume=106&rft.issue=12%20Suppl%201&rft.spage=I63&rft.epage=I68&rft.pages=I63-I68&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.cir.0000032900.55215.85&rft_dat=%3Cproquest_cross%3E208135471%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c511t-9b175f59ab684093b66666175b4b40959515057011b2312cb2b00352db1d463c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=212676970&rft_id=info:pmid/12354711&rfr_iscdi=true